Join
Live feed
·
INSIDERFilingvia Quantisnow
BridgeBio Pharma Inc. logo

Chief Accounting Officer Apuli Maricel sold $160,120 worth of shares (2,000 units at $80.06) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 127,401 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
BBIO· BridgeBio Pharma Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BBIO (BridgeBio Pharma Inc.) and more on Quantisnow.